Hemab Therapeutics Holdings, Inc. ( COAG ) Q3 2026 Earnings Call November 10, 2026 8:00 AM EST
Company Participants
Benny Sorensen - President, CEO & Director
Mads Behrndt-Eriksen - CFO & GM
Conference Call Participants
David Nierengarten - Wedbush Securities Inc., Research Division
Jin Law - Goldman Sachs Group, Inc., Research Division
Maurice Raycroft - Jefferies LLC, Research Division
Joyce Zhou - JPMorgan Chase & Co, Research Division
Gaurav Maini - LifeSci Capital, LLC, Research Division
Michael King - Rodman & Renshaw Research
Presentation
Operator
Welcome to Hemab Therapeutics Third Quarter 2026 Conference Call. Leading the call from management are Benny Sorensen, Chief Executive Officer; and Mads Behrndt, Chief Financial Officer.…